Ribosome biogenesis requires a vast number of trans-acting factors many of which are required for the chemical modi®cation and processing of the pre-rRNA component. The U3 snoRNP complex is required for the early cleavage steps in pre-rRNA processing. We have cloned cDNAs encoding the human and mouse homologs of the yeast U3 snoRNP-associated proteins Imp3 and Imp4. Both human proteins localize to nucleoli and interact with the U3 snoRNA. The results of complementation experiments show that, in contrast to mouse Imp4, mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of Imp3 in pre-rRNA processing is evolutionarily conserved. The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60±80S ribonucleoprotein complexes. In addition, we have found that hImp3, hImp4 and hMpp10 can form a stable hetero-trimeric complex in vitro, which is generated by direct interactions of both hImp3 and hImp4 with hMpp10. The analysis of hImp3 and hImp4 mutants indicated that their binding to hMpp10 correlates with their nucleolar accumulation, strongly suggesting that the formation of the ternary complex of hImp3, hImp4 and hMpp10 is required for their association with nucleolar components.
INTRODUCTION
The U3 small nucleolar RNA (snoRNA), a box C/D type snoRNA, is required for the early cleavage steps in pre-rRNA processing, which are essential for the formation of the small ribosomal subunit RNA (18S rRNA) in both fungi and vertebrates (1±3). In yeast, the U3 snoRNA is essential for processing at sites A 0 , A 1 and A 2 (reviewed in 4). Base-pairing interactions of the U3 snoRNA with the 5¢ external transcribed spacer (5¢ETS) of the precursor ribosomal RNA (pre-rRNA) and the 5¢ terminal region of the 18S rRNA have been demonstrated to play an essential role in this process.
The U3 snoRNA contains several evolutionarily conserved sequence elements, designated box GAC, A, A¢, B, C, C¢ and D. The box GAC, box A and box A¢ display sequence complementarity to regions of the 5¢ETS and 18S rRNA sequences within the pre-rRNA (5±14). The boxes B/C and C¢/D are located in the 3¢ part of the U3 snoRNA and function as protein binding sites (10, 15, 16) .
The U3 snoRNA interacts with proteins that are common to all box C/D snoRNPs: 15.5K (Snu13p in yeast), Nop56, Nop58 and ®brillarin (Nop1p) (16±24). In addition, a number of proteins have been identi®ed in a yeast system that speci®cally associate with the U3 snoRNA: Rrp9p (hU3-55K in human), Dhr1p, Lcp5p, Rcl1p, Sof1p, Imp3p, Imp4p and Mpp10p (hMpp10 in human) (reviewed in 25) .
Puri®cation of the yeast~80S SSU processome has led to the identi®cation of a vast number of novel proteins that interact with the U3 snoRNA (26) . With the exception of Rcl1p and Lcp5p, these complexes contained all U3 snoRNA-associated proteins mentioned above and a large number of other nonribosomal proteins that are associated with the U3 snoRNA. It has been proposed that the U3 snoRNA, together with the proteins that are associated with U3 in the SSU processome, is required to assist in the proper folding of the pre-rRNA.
The human U3 snoRNA is associated with both 12S and 60±80S complexes (27, 28) . Nop56, Nop58, 15.5K, ®brillarin and hU3-55K are most likely to be the ®rst proteins to interact with the U3 snoRNA during its assembly and together may constitute the 12S U3 complex (16±18). Base-pairing interactions of the U3 snoRNA with pre-rRNA, which may require a number of auxiliary factors, may lead to the formation of 60±80S complexes, equivalent to the SSU processome described in yeast (26) .
Imp3p and Imp4p were identi®ed in a yeast two-hybrid screen using yeast Mpp10p as a bait (29) . Both the human and yeast Mpp10 proteins contain several putative coiled-coil regions that have been suggested to mediate intramolecular and/or intermolecular interactions (30±32). Imp3p contains a putative S4 RNA binding domain (29) . Imp4p is a member of the Imp4 superfamily of proteins, which are characterized by the s 70 -like motif, a sequence motif ®rst identi®ed in the s 70 family of prokaryotic transcription factors (33) . Interestingly, the s 70 -like motif in the eukaryotic Imp4 superfamily confers binding to RNA and all the proteins in this family interact with pre-rRNA processing intermediates (33) . In contrast to other members of this family, Imp4p associates with the U3 snoRNA and is required for the early cleavage steps in prerRNA processing (29, 33) . In this study we have addressed the question whether the Mpp10-Imp3-Imp4 complex also exists in human cells and we have investigated its association with the human U3 snoRNP. For these studies cDNAs encoding the human homologs of the yeast Imp3 and Imp4 proteins were cloned and characterized. Besides data on their association with U3 snoRNA-containing complexes, details on their interactions with the human Mpp10 protein will be presented. mImp3A: 5¢-GCGAGATCTCTCGAGATGGTGCGGAAG-CTTAAGTTC-3¢; hImp3: 5¢-GCGAGATCTAGGCCTC-TAGCTAGCGGCTTCTAGATCAAAGTCATC-3¢; hImp4a:  5¢-GCGAGATCTCTCGAGATGCTGCGCCGCGAGGCC-CGC-3¢; hImp4b: 5¢-GCGAGATCTAGGCCTTCAGCT-AGCCTCGGTGCTCAGGAAGCATCT-3¢; hImp3DS4: 5¢-GCGAGATCTAGGCTTCTAGCTAGCGGCGGGGTCGGT-GACCAC-3¢; hImp3DCCRev: 5¢-CGAAGCGCGCACGCG-GAACTGCAGCCGGTAACGCCCGCAGCAC-3¢; hImp4-DCCFor: 5¢-GCGCTCGAGCGCCTGATTCCCACTGAG-TTA-3¢; hImp4Ds70For: 5¢-AAGAAGACAGACCACCG-CAACCTGGGCACGCTGGAGCAGGAG-3¢; hImp4s70ER-AA: 5¢-GTGGAGCTCACTGCGGTCGGGCCCGCGTTTG-AGCTGAAGCTGTACATG-3¢; hImp4TFAAFor: 5¢-AGC-CACCTGCCCTTTGGTCCTGCGGCCTACGCGACGCTG-TGCAATGTGGTCATG-3¢; hImp4TFAARev: 5¢-CATGA-CCACATTGCACAGCGTCGCGTAGGCCGCAGGACCA-AAGGGCAGGTGGCT-3¢; mImp3Bam: 5¢-CGCGGATC-CATGGTGCGGAAGCTTAAGTTC-3¢ .
MATERIALS AND METHODS

Oligonucleotides used in this study
DNA manipulations
The human Imp3 and Imp4 cDNAs were cloned by PCR using a teratocarcinoma cDNA library and oligonucleotides mImp3a and hImp3, hImp4a and hImp4b, respectively. The PCR products were cloned into the pCR4-TOPO vector according to manufacturer's procedure (Invitrogen). The resulting constructs contain in-frame BglII restriction sites at both the 5¢ and 3¢ end, a XhoI restriction site upstream of the translational start codon and an NheI and StuI site at the 3¢ end in-frame with the coding sequence. The integrity of each construct was veri®ed by DNA sequencing.
A mouse EST bearing a portion of the putative mouse Imp3 homolog (mImp3) was identi®ed by searching with the yeast Imp3 protein sequence. The clone was obtained from Research Genetics (cDNA ID: 634066), and the insert was used to screen a mouse myeloid leukemia cDNA library cloned into the l-Zap vector (LTR6; provided by Hui Zhang, Yale University) to obtain a full-length mImp3 clone. For subcloning, primers for PCR ampli®cation were made (mImp3Bam and a T7 primer). The BamHI site in the 5¢ primer and an existing XhoI site in the 3¢ UTR were used to clone mImp3 into yeast expression vectors. The mouse Imp4 cDNA was cloned as described previously (33) . The yeast U3 snoRNA expression vector used in this study has been described previously (34) . The pEGFPhImp3 and pEGFPhImp4 constructs were generated by inserting XhoI±BglII fragments of the cDNA constructs into the pEGFP-C3 vector (Clontech) digested with XhoI and BamHI. The pCI-neoVSVhImp constructs were generated by insertion of the XhoI±StuI fragments in plasmid pCIneo5¢VSV (35) digested with XhoI and SmaI. The resulting constructs contained a VSV-G sequence in-frame with the translational start codon. The pGEX-2T GST-fusion constructs were generated using the BglII and StuI digested cDNA plasmids. hImp3DS4 mutant was generated by PCR using oligonucleotides hImp3DS4 and mImp3a. The PCR product was gel puri®ed and cloned into pCR4-TOPO (Invitrogen). The hImp3DCC mutant was generated by two sequential PCRs. In the ®rst round of PCR, oligonucleotide hImp3DCCRev was used in combination with oligonucleotide mImp3a. The PCR product was gel puri®ed and used as a primer in a second reaction in combination with oligonucleotide hImp3. The resulting PCR product was cloned into pCR4-TOPO (Invitrogen). hImp4DCC was generated using oligonucleotides hImp4DCCFor and hImp4b and cloned into pCI-neo5¢VSV and pEGFP-C3 using the XhoI and SmaI restriction sites. The hImp4Ds70 mutant was generated using oligonucleotides hImp4Ds70For, hImp4b and hImp4a via the megaprimer procedure as described above.
To generate the hImp4s 70 ERAA mutant, a PCR was performed with oligonucleotides hImp4s70ERAA and hImp4b. The PCR product was subsequently cloned into pCR4-TOPO, isolated by SstI and StuI digestion and ligated into pCR4-TOPOhImp4 digested with the same enzymes. The hImp4TFAA mutant was generated using the oligonucleotides hImp4TFAAFor and hImp4TFAARev and the QuikChange mutagenesis kit according to the manufacturer's procedure (Stratagene)
All mutant hImp3 and hImp4 constructs were subsequently digested with XhoI and StuI and cloned into pCI-neo5¢VSV and pEGFP-C3 using the XhoI and SmaI restriction sites. The hImp3DS4 VSV and GFP-fusion constructs were generated by digesting pCR4TOPOhImp3DS4 with XhoI and EcoRI followed by ligation of the gel puri®ed cDNA in the pCIneo5¢VSV and pEGFPC3 vectors digested with the same enzymes To generate pCI-neoVSVhMpp10, a XhoI site was introduced by PCR [pBS SK+ Mpp10 as template (32) ] upstream of the translational start codon and XbaI and SmaI sites at the 3¢ end. A XhoI±SmaI digested cDNA was inserted into pCIneo5¢VSV digested with the same enzymes. The resulting construct contained a VSV-G tag in frame with the Mpp10 cDNA. The GFPhMpp10 deletion mutant constructs were generated by digestion with appropriate restriction sites. The following internal restriction sites of the hMpp10 cDNA were used: BamHI (DN58); PvuII (DC567); NdeI (DC456); HindIII (DC325); EcoRV and HindIII (D103±326). The integrity of each construct was veri®ed by DNA sequencing.
Yeast manipulations
The mImp3 gene was placed under the control of a constitutive yeast promoter on both the p415GPD (LEU2 gene as marker) and p416GPD (URA3 gene as marker) vectors. The p415GPD-mImp3 was shuf¯ed into yeast strain (pGAL1::Imp3) as previously described (29) and grown at 22°C. This strain was designated mouse Imp3 (mImp3).
Mpp10p homologs were expressed from p415GPD, a single copy plasmid, or p425GPD, a multicopy plasmid (30, 36) .
In order to concurrently overexpress various homologs of IMP3 and MPP10 in the same strain the following strains were created by switching the p415GPD mImp3 plasmid for the p416GPD mImp3 or p416GPD yeast Imp3p plasmid by a modi®ed plasmid shuf¯e. The mImp3 strain was transformed with either p416GPD Imp3 plasmids and grown on SD±Ura media. Individual colonies were then struck out on SD. Cells that had lost p415GPD mImp3 and now only carried p416GPD mImp3 or p416GPD yImp3 were then transformed with the plasmids containing the MPP10 genes and selected on SD±Leu, Ura media. For serial dilutions yeast were grown to saturation in SD±Leu or SD±Leu, Ura, to select for strains with plasmids containing homologs of MPP10 or U3 gene. Cells (2 Q 10 7 ) were diluted 10-fold and spotted onto plates containing the appropriate selective media. The plates were then grown at 22 or 30°C for 2 days.
Fluorescence microscopy
HEp-2 monolayer cells were grown to 70% con¯uency in DMEM supplemented with 10% fetal calf serum (FCS). Cells (2 Q 10 6 ) were transfected with 20 mg of DNA in a total volume of 800 ml DMEM/10% FCS. Electroporation was performed at 260 V at a capacity of 950 mF with a Gene Pulser II (BioRad). After electroporation, cells were resuspended in 5 ml DMEM/10% FCS, grown for 16 h on coverslips before further processing. Coverslips were washed twice with phosphate buffered saline (PBS), placed in methanol for 5 min at ±20°C and rinsed with acetone at room temperature. GFP-fusion proteins were visualized by¯uorescence microscopy directly after cells were ®xed and permeabilized. Images were obtained using an Olympus BH2 microscope in combination with an Olympus DP10 digital camera and analySIS software (Soft Imaging System GmbH).
Glycerol gradient sedimentation and immunoprecipitation experiments
A T150¯ask with HEp-2 cells was grown to 70% con¯uency using the conditions described above. Cells were harvested and disrupted in 1 ml gradient buffer [20 mM HEPES±KOH (pH 7.9), 150 mM NaCl, 0.5 mM DTT] by sonication (Branson microtip setting 2±3) for 3 Q 20 s. Triton X-100 was added to 0.2% (v/v) and insoluble material was removed by centrifugation at 10 000 g in a microcentrifuge. The supernatant (1 ml) was loaded on a 10±30% glycerol gradient (v/v) prepared in gradient buffer containing 0.2% Triton X-100. Gradients were centrifuged in a Th674 rotor (Sorvall) for 15 h at 25 000 r.p.m. Gradients were manually fractionated in 22 fractions each. Fractions were subjected to phenol/ chloroform/isoamylalcohol (25:24:1) extraction and the RNA was isolated by ethanol precipitation. Proteins were precipitated by the addition of 5 vol of acetone to the organic phase. RNAs were resolved on 10% denaturing polyacrylamide gels and transferred to Hybond N + (Amersham). Hybridization of blots with antisense snoRNA probes was performed as described previously (35) . The positions of the 18S and 28S rRNAs were determined by agarose gel electrophoresis and ethidium bromide staining.
For immunoprecipitations, antibodies were coupled to protein A agarose beads either directly [anti-hU3-55K, anti-hMpp10, anti-(tri)methylguanosine cap (H20)] or via rabbit anti-chicken IgY antibodies (Jackson Immunoresearch) (anti-hImp3, anti-hImp4). Immunoprecipitations shown in Figure 2 were performed using fresh HEp-2 cell lysates prepared in gradient buffer as described above. After incubation with extracts (2 h, 4°C), beads were washed four times with gradient buffer and co-precipitated RNAs were isolated by phenol:chloroform:isoamylalcohol extraction and ethanol precipitation. RNA was resolved on 6% PAA/7 M urea gels. For the immunoprecipitation experiment shown in Figure 4 , fractions 4±7 and 16±20 of the glycerol gradient were pooled and 450 ml was incubated with the antibodies coupled to protein A beads or beads alone for 2 h at 4°C. Wash steps and extraction of co-precipitated RNAs was performed as described above and RNA was resolved on 10% PAA/7 M urea gel.
Expression and puri®cation of GST-fusion proteins
GST-fusion proteins were expressed and puri®ed essentially as described previously (37) . The proteins were eluted in the presence of 0.2% Triton X-100 and stored at ±70°C after the addition of glycerol (10%).
In vitro transcription and translation
All pCI-neoVSV constructs were transcribed and translated in reticulocyte lysate using either the TnT coupled transcription/translation kit (Promega), or by run-of transcription and translation using manufacturers procedures (Promega). To generate hMpp10 deletion mutant translates, pCIneoVSVhMpp10 was digested with the corresponding enzymes as described above.
GST pull-down experiments
GST-fusion protein (500 ng) was incubated with radiolabeled in vitro translated protein in buffer A [20 mM HEPES±KOH (pH 7.9), 150 mM KCl, 0.2% Triton X-100, 1.5 mM MgCl 2 , 0.2 mM EDTA] in a ®nal volume of 20 ml. Reactions were incubated for 1 h on ice. Subsequently, the reaction mixtures were diluted to 250 ml with buffer A, 10 ml of glutathione± Sepharose beads were added and the mixture was incubated by end-over-end rotation for 2 h at 4°C. Beads were washed four times with buffer A. Proteins were eluted from the beads by adding SDS sample buffer and heating for 5 min at 100°C. Co-precipitated proteins were separated by SDS±PAGE and visualized by autoradiography.
Generation of antisera
Female white chickens were immunized with 50 mg of puri®ed GST-fusion protein and boosted every two weeks with the same amount of protein. Two chickens were used for immunization with GSThImp3 (006 and 007) and two for immunization with GSThImp4 (008 and 009). The 007 and 008 bleeds showed signi®cant reactivity on western blots with the corresponding HeLa cell and recombinant proteins as well as in immunoprecipitation of the recombinant in vitro translated proteins and thus were used for further experiments.
Af®nity-puri®cation of antibodies
Anti-hU3-55K antibodies (38) were af®nity-puri®ed using the peptide that was used for the immunizations coupled to Sulfolink resin as described by the manufacturer's procedure (Pierce).
Western blot analysis
Western blots loaded with gradient fractions were blocked in MP buffer [PBS, 5% non-fat milk powder, 0.1% NP-40 (v/v)] for 1 h at room temperature. Primary antibody was diluted in MP buffer and incubated for 1 h at room temperature. Blots were washed three times for 10 minutes with MP buffer, followed by a 1 h incubation with the secondary antibody. Antibodies used: chicken anti-hImp4, diluted 1:10 000; chicken anti-hImp3, diluted 1:5000; af®nity puri®ed antihU3-55K antibodies 1:100; guinea pig anti-hMpp10 antibodies, 1:2000 (a kind gift from Dr Larry Gerace) (32) . As secondary antibodies, horseradish peroxidase conjugated rabbit anti-mouse (1:2500), rabbit anti-guinea pig (1:2500), swine anti-rabbit (1:2500) or rabbit anti-chicken IgY (1:20 000) were used. Except for the rabbit anti-chicken antibodies (Jackson Immunoresearch), all secondary antibodies were purchased from Dako (Glostrup, Denmark).
RESULTS
Cloning of cDNAs encoding the mammalian Imp3p and Imp4p homologs
Database searches performed with the yeast Imp3 and Imp4 sequences led to the identi®cation of putative Imp3p and Imp4p homologs in a number of species, several of which have been reported before (29, 33, 39, 40) . Human and mouse Imp3 and Imp4 cDNAs were isolated and sequenced. The amino acid sequence derived from the cloned human Imp4 cDNA (hImp4) was identical to the putative human Imp4p homolog recently described (40) (accession number: AF054996). While this work was in progress, a protein designated MRPS4, the sequence of which is identical to the sequence derived from the cloned human Imp3 cDNA (hImp3), was described as a mitochondrial ribosomal subunit component (accession numbers: BAB54955 and NP_060755), although no experimental evidence for its association with the mitochondrial ribosome was presented (41) . Figure 1 shows an alignment of Imp3 and Imp4 amino acid sequences. Both the human and mouse Imp3 and Imp4 proteins have predicted molecular masses of 21.8 and 33.7 kDa, respectively. Both mammalian Imp proteins display~50% identity and 65% similarity to their yeast counterparts.
Besides a putative S4 domain in hImp3 and a s 70 -like motif in hImp4, coiled-coil regions are predicted to reside in both human proteins (Fig. 1) . The Interproscan program (http://www.ebi.ac.uk/interpro/scan.html) revealed the so-called Imp4 domain (InterProScan ID: Q96G21) that was recently identi®ed in Imp4 homologs from several species (40) .
The hImp3 and hImp4 proteins localize to nucleoli and interact with the human U3 snoRNP complex
To investigate whether the hImp3 and hImp4 cDNAs encoded the functional counterparts of the yeast Imp3p and Imp4p proteins, their subcellular localization and association with the U3 snoRNP were determined. HEp-2 cells were transfected with constructs encoding GFP-fusion proteins of hImp3 and hImp4 and after 18 h the subcellular localization of the GFPtagged proteins was examined by¯uorescence microscopy. The results show that both fusion proteins accumulate in the nucleoli (Fig. 2A) . Thus, the subcellular localization of hImp3 and hImp4 is consistent with U3 snoRNP association and a role in ribosomal RNA maturation. To investigate whether these proteins indeed associate with U3, immunoprecipitations were performed with anti-hImp3 and anti-hImp4 antibodies on HEp-2 total cell extracts (Fig. 2B, lanes 3 and 4) . As controls anti-hMpp10, anti-hU3-55K, anti-®brillarin and anti-(tri)methylguanosine cap antibodies were used (Fig. 2B , lanes 4±7). After immunoprecipitation, co-precipitated RNAs were analyzed by northern blot hybridization using various riboprobes. We observed U3 snoRNA co-precipitation with both the anti-hImp3 and anti-hImp4 antibodies, although the amounts were reproducibly low (Fig. 2B, lanes 2 and 3) . Co-precipitation of U3 with the anti-hImp4 antibodies was always more ef®cient than with anti-hImp3 antibodies. As expected, the U3 snoRNA ef®ciently co-precipitated with the anti-®brillarin and anti-cap antibodies (Fig. 2B, lanes 6 and 7) .
The mouse Imp3 protein partially complements a yeast imp3 null strain
The association of hImp3 and hImp4 with the U3 snoRNP complex and their subcellular localization suggests that these proteins are involved in pre-rRNA processing and thus indeed represent functional counterparts of the respective yeast proteins. To substantiate this, we investigated whether the expression of the mammalian Imp3 and Imp4 proteins in yeast could complement the respective yeast null alleles. As evident from Figure 3A , the expression of mouse Imp3 (mImp3) partially complemented an imp3 null allele in yeast at 22°C, whereas mouse Imp4 (mImp4) did not complement the imp4 null allele.
Interestingly, the growth defect conferred by mImp3 could be partially alleviated by over-expressing other members of the yeast SSU processome, including Mpp10p and the yeast U3 snoRNA (Fig. 3B) . Homologs of Mpp10p from different species and the U3 snoRNA were over-expressed at different levels in a yeast strain expressing either mImp3 or yeast Imp3. Most notably, Drosophila melanogaster Mpp10 (dMpp10p) suppressed the growth defect the best at both 22 and 30°C (Fig. 3B) . This is most likely due to the fact that dMpp10p and yeast Mpp10p share a higher degree of conservation than yeast and mouse Mpp10 (33) . Over-expression of the U3 snoRNA also alleviated the growth defect of the yeast mImp3 strain, although to a lesser extent than dMpp10p. Very high levels of Mpp10p (expressed from p425GPD) had a negative effect on growth suggesting that the Mpp10p must be tightly regulated. Likewise depletion of Mpp10p in yeast leads to a decrease of Imp3p and Imp4p protein levels (33) and over-expression of Mpp10p also increases the levels of Imp3p and Imp4p (S.Wormsley and S.J.Baserga, unpublished). Co-over expression of all three is lethal (data not shown) suggesting that this dominant negative affect could be due to dilution of other factors associated with these proteins.
hImp3, hImp4 and hMpp10 sediment at 60±80S in glycerol gradients
The human U3 snoRNA is associated with 12S and 60±80S complexes of which the latter probably represent the U3 snoRNA associated with pre-rRNA processing complexes Figure 1 . Amino acid sequence alignment of Imp3 and Imp4. Amino acid sequences derived from cDNAs encoding Imp3 (A) and Imp4 (B) of Homo sapiens (hs), Mus musculus (mm), D.melanogaster (dm), Caenorhabditis elegans (ce), Arabidopsis thaliana (at) and S.cerevisiae (sc) were aligned by ClustalW and shaded using Boxshade. Identical amino acids (in at least three of the sequences) are marked by black boxes and similar amino acids are marked by gray boxes. The boxed regions mark the predicted coiled-coil domains. The black bar in (A) underlines the putative S4 RNA binding domain of Imp3. The black bar in (B) underlines the putative s 70 -like RNA binding domain of Imp4. The broken line in (B) indicates the position of the Imp4 domain. Accession numbers: dmImp3, AAL49156; ceImp3, NM_059571, atImp3, NM_121580; mmImp3, BC009145; hsImp3, BAB54955 and NP_060755; scImp3p, AA184637; dmImp4, AE003750; ceImp4, AF334609; atImp4, AC011622; hsImp4, AF054996; mmImp4, XP_129730; scImp4p, AA404192. 26±28,42) . Since most of the yeast U3 snoRNA-associated proteins have been reported to interact with the RNA in higher order complexes (26, 42, 43) , the association of hImp3 and hImp4 with the U3 snoRNP was further studied by density gradient sedimentation. Since yeast Imp3p and Imp4p interact with Mpp10p (29), we included the human Mpp10 protein in these analyses. In addition, the sedimentation of hU3-55K, a U3 snoRNP speci®c protein, was investigated (35, 44) . HEp-2 cell extracts were fractionated in 10±30% glycerol gradients. Northern blotting revealed that the bulk of the U3 snoRNA sedimented at 12S and 60±80S, in agreement with previous observations (27, 28) . The U3-speci®c protein hU3-55K cosedimented with the U3 snoRNA, and peaked with the U3 snoRNA in fractions 5±6 (~12S) and fractions 17±19 (~70S). Interestingly, the bulk of hImp3, hImp4 and hMpp10, cosedimented with the U3 snoRNA at 60±80S (Fig. 4A, fractions  17±19 ), whereas only very small amounts sedimented near 12S (Fig. 4A, fractions 4±7) . These results suggested that, in contrast to hU3-55K, the hImp3, hImp4 and Mpp10 proteins are not associated with the 12S U3 complex, but that they only interact with the larger, 60±80S U3 snoRNA-containing complexes. Immunoprecipitation experiments performed with anti-hU3-55K, anti-hMpp10 and anti-hImp4 antibodies (Fig. 4B, lanes 7±9 ) con®rmed the interaction between these proteins and the U3 snoRNA in the 60±80S fractions. Furthermore, only very low amounts of U3 snoRNA were co-precipitated by anti-hImp4 and anti-hMpp10 antibodies from 12S fractions (Fig. 4B, lanes 3±5 ).
Nucleic Acids
Research, 2003, Vol. 31, No. 7 1881 (
hMpp10, hImp3 and hImp4 form a hetero-trimeric complex in vitro
In yeast, the Imp3p and Imp4p proteins were identi®ed by virtue of their interaction with Mpp10p (29) . To study whether the human proteins also directly bind to each other, GST pulldown experiments were performed using GSThImp3, GSThImp4 and 35 S-labeled, in vitro translated hImp3, hImp4 and hMpp10 proteins. The GST-fusion proteins and radiolabeled proteins were incubated and the complexes that were formed were precipitated using glutathione±Sepharose beads. The results in Figure 5 show that GSThImp3 and GSThImp4 ef®ciently interacted with hMpp10 (lanes 4 and 5). In contrast, no detectable interaction was observed between GSThImp3 and hImp4 and between GSThImp4 and hImp3 (Fig. 5, lanes 6 and 7) . These results suggest that, like their yeast counterparts, hImp3 and hImp4 interact with Mpp10 but not with each other. In agreement with these interactions, hetero-trimeric complexes could be reconstituted in vitro when either GSThImp3 was incubated with radiolabeled hMpp10 and hImp4 (Fig. 5, lane 8) or when GSThImp4 was incubated with radiolabeled hMpp10 and hImp3 (Fig. 5,  lane 9) . When GST15.5K was used in these experiments, no detectable co-precipitation of radiolabeled hImp3, hImp4 or hMpp10 (Fig. 5, lane 10) was observed.
Domains of hImp3, hImp4 and hMpp10 involved in mutual interactions
The ef®cient interactions between hImp3, hImp4 and hMpp10 prompted us to examine the regions involved in their mutual Figure 2 . hImp3 and hImp4 localize to nucleoli in HEp-2 cells and interact with the U3-snoRNA in vivo. (A) HEp-2 cells were transfected with constructs encoding GFPhImp3 and GFPhImp4 fusion proteins and after 16 h cells were ®xed and the subcellular localization of the fusion proteins was determined by¯uorescence microscopy (right panels). The corresponding phase-contrast images are shown in the left panels. (B) HEp-2 total cell extracts were subjected to immunoprecipitation using antibodies against hImp3, hImp4, hMpp10, hU3-55K, ®brillarin (27B9) and anti-cap antibodies (H20) (lanes 2±7). Co-precipitated RNAs were separated on denaturing polyacrylamide gels and analyzed by northern blot hybridization using a U3 snoRNA speci®c probe. In lane 1, RNA isolated from the total cell extract was loaded (5% of the amount used for immunoprecipitation) and as a negative control an immunoprecipitation was performed in the absence of antibodies (beads, lane 8). interactions. Five hMpp10 deletion mutants were generated (Fig. 6A) and analyzed by GST pull-down experiments. The results show that GSThImp3 ef®ciently bound to hMpp10DN58, hMpp10D103±326 and hMpp10DC565, but not to hMpp10DC456 and hMpp10DC325 (Fig. 6B, lanes  8±12) . GSThImp4 bound to all mutants (Fig. 6B, lanes 14±18 ) with the exception of hMpp10DC325. These results suggest that the region of hMpp10 bordered by amino acids 457 and 565 is required for its interaction with hImp3, whereas the region bordered by amino acids 327±456 is involved in the binding to hImp4 (Fig. 6C) .
To investigate the regions of hImp3 and hImp4 involved in the interaction with hMpp10, the capacity of hImp3 and hImp4 deletion mutants (Fig. 7A) to interact with in vitro translated hMpp10 bound to GSThImp4 and GSThImp3, respectively, was determined. Deletion of either the putative coiled-coil domain of hImp3 or the C-terminal region including part of the S4 domain abrogated the interaction with hMpp10 (Fig. 7B,  lanes 6 and 7) . Deletion of the putative coiled-coil region of hImp4 did not affect its interaction with hMpp10 (Fig. 7C,  lane 6) . However, deletion of the s 70 -like motif abrogated its interaction with hMpp10 (Fig. 7C, lane 7) . These data indicate that the deletion of spatially separated regions of hImp3 interfere with its binding to hMpp10 and that the s 70 -like motif of hImp4 is required for its association with hMpp10. To substantiate the importance of the s 70 -like motif for this interaction and to investigate the possibility that (also) the Imp4 domain plays a role in this interaction, we generated amino acid substitution mutants. Two highly conserved amino acids in the s 70 -like motif (E246 and R250) or the Imp4 domain (T159 and F162) were substituted by alanines (Fig. 7A, hImp4s 70 ERAA and hImp4TFAA) (33, 40) . The results show that both mutants did not ef®ciently interact with hMpp10 (Fig. 7D, lanes 6±8) , suggesting that the s 70 -like motif and conserved amino acids in the hImp4 domain are important for binding to hMpp10 in vitro.
Complex formation de®cient hImp3, hImp4 and hMpp10 mutants fail to localize to nucleoli in HEp-2 cells
To determine the effects of the deletions and substitutions in the hImp3, hImp4 and hMpp10 proteins on their nucleolar accumulation, HEp-2 cells were transiently transfected with constructs encoding GFP-fusion proteins of these mutants. Interestingly, all hImp3 and hImp4 mutants that failed to interact with hMpp10 in vitro predominantly accumulated in the nucleoplasm (Fig. 8C, D, G, H and I) , whereas the hImp4 mutant that retained the ability to interact with hMpp10 accumulated in the nucleoli like the wild-type proteins (Fig. 8B, E and F) . These results suggest that the interaction of hImp3 and hImp4 with hMpp10 is required for their entry into the nucleolus. . hImp3 and hImp4 interact with hMpp10 but not with each other in vitro. Radiolabeled hMpp10, hImp3 and hImp4 were expressed in an in vitro translation system (lanes 1±3). These polypeptides were incubated with GST-tagged hImp3 or hImp4 as indicated, followed by precipitation with immobilized glutathione (lanes 4±9). A GST15.5K fusion protein was used as a control (lane 10). Note that hImp4 is only co-precipitated with GSThImp3 in the presence of hMpp10 and that, vice versa, hImp3 is only co-precipitated with GSThImp4 in the presence of hMpp10. The positions of radiolabeled hMpp10, hImp3 and hImp4 in the gel are indicated on the right. On the left of each panel the positions of molecular mass markers are shown. Figure 4 . hImp3, hImp4 and hMpp10 predominantly sediment at 60±80S in glycerol gradients. (A) HEp-2 cell lysates were loaded on a 10±30% (v/v) glycerol gradient, and the sedimentation of U3 snoRNA, hU3-55K, hMpp10, hImp3 and hImp4 was analyzed by northern blot hybridization and immunoblotting, respectively. The sedimentation of the large ribosomal RNAs was determined by agarose gel electrophoresis and ethidium bromide staining and these were used as markers for 40S and 60S particles in the gradient. The U1 snRNA was used as a marker for 12S complexes (data not shown). The arrow marks the hImp3 band. (B) The fractions containing either the 12S or 60±80S U3 snoRNP complexes (4±7 and 16±20) were pooled and used for immunoprecipitation experiments with anti-hU3-55K (lanes 2 and 7), anti-hMpp10 (lanes 3 and 8) and anti-hImp4 (lanes 4 and 9) antibodies. RNAs isolated from the pooled fractions (5% input, lanes 1 and 6) and co-precipitated RNAs were separated on denaturing polyacrylamide gels and analyzed by northern blot hybridization using a U3 snoRNA speci®c probe. As a negative control an immunoprecipitation was performed in the absence of antibodies (beads, lanes 5 and 10).
The analysis of the GFPhMpp10 fusion proteins suggested that also hMpp10 requires the interaction with hImp3, and possibly hImp4, for nucleolar localization. The wild-type protein (GFPhMpp10), the N-terminal deletion mutant (GFPhMpp10DN58) and the internal deletion mutant (GFPhMpp10D103±326) accumulated in nucleoli (Fig. 8J±L) . Thus a large portion of the N-terminal part of hMpp10 can be deleted without affecting its subcellular distribution. Interestingly, a C-terminal deletion of 116 amino acids (GFPhMp10DC565) resulted in both nucleolar and cytoplasmic accumulation, while only weak staining was observed in the nucleoplasm (Fig. 8M) . The most pronounced nucleolar accumulation with this mutant was observed in cells expressing relatively low levels of the fusion protein ( Fig. 8M ; indicated by an arrow). The cytoplasmic accumulation might be related to the amino acid composition of the region that was deleted, which contains clusters of basic amino acids that might be involved in nuclear import (32) . The larger C-terminal deletion mutant GFPhMpp10DC456 predominantly accumulated in the cytoplasm (Fig. 8N) , whereas only very small amounts appeared to reside in the nucleoplasm. Similar observations were made with the GFPhMpp10DC325 mutant (data not shown). With these mutants no signi®cant staining was observed in the nucleoli. Taken together, these results suggest that the region in hMpp10 that is important for binding hImp3 (amino acids 456±565) is also required for nucleolar localization, while the C-terminal region comprising amino acids 565±681 is required for nuclear import.
DISCUSSION
In this paper we describe the cloning and characterization of mammalian Imp3p and Imp4p homologs. Our data show that like in the yeast Saccharomyces cerevisiae the hImp3 and hImp4 proteins both interact with hMpp10, but not with each other. Furthermore, they indicate that hImp3, hImp4 and hMpp10 predominantly associate with the U3 snoRNA in 60±80S complexes, which are likely to represent preribosomal complexes. The results obtained with hImp3, hImp4 and hMpp10 mutants suggest that the nucleolar accumulation of these proteins is dependent on formation of the ternary complex.
hImp3 and hImp4 interact with the U3 snoRNA in 60±80S U3 snoRNA-containing particles
Previously it has been shown that the yeast Imp3p and Imp4p proteins speci®cally interact with the U3 snoRNP complex (29) . Our immunoprecipitation data indicate that this also occurs in the human system. Despite the fact that a considerable amount of U3 snoRNA co-sedimented with hImp3 and hImp4 in glycerol gradients, we reproducibly observed a relatively inef®cient U3 snoRNA co-precipitation, indicating that only a small amount of U3 snoRNA is stably associated with these proteins in HEp-2 cells. We obtained similar results with anti-GFP immunoprecipitations using extracts prepared from transiently transfected HEp-2 cells expressing GFPtagged hImp3 or hImp4 (data not shown). The possibility that the inef®cient co-precipitation was due to a poor accessibility of the hImp3 and hImp4 proteins for the antibodies in the 60±80S U3 complexes cannot be excluded.
The results of gradient sedimentation analyses suggested that hImp3, hImp4 and hMpp10 are ef®ciently associated with 60±80S complexes, at least part of which also contain the U3 snoRNA. U3-containing complexes with a similar sedimentation behavior have been reported by Tyc and Steitz using HeLa cell extracts (28) . Components of the yeast~80S SSU processome are associated with pre-rRNA (J.E.G.Gallagher and S.J.Baserga, unpublished results) (42) and these complexes have been suggested to represent the terminal balls seen on nascent pre-rRNA transcripts (26, 42, 46, 47) . Attempts to demonstrate the association of pre-rRNA by immunoprecipitation with anti-hImp and anti-hMpp10 antibodies from 60±80S gradient fractions were not successful. This is most likely due to the low abundance of these precursors in the cell and low stability of these RNAs. However, based on recent studies performed in yeast (26, 42) , it is likely that the human U3 complexes sedimenting at 60±80S are associated with pre-rRNA precursors. Our results are consistent with the formation of a relatively stable trimeric complex of Imp3, Imp4 and Mpp10, which interacts with the U3 snoRNA only when it is associated with higher order complexes. The formation of such a trimeric complex is supported by af®nity-puri®cations using tagged Mpp10p expressed in yeast cells, which yielded Mpp10p, Imp3p and Imp4p and no other SSU processome components (F.Dragon, S.Wormsley and S.J.Baserga, unpublished observations). The ef®cient association of hImp3, hImp4 and hMpp10 with large complexes suggests a model in which U3 is recruited to the pre-rRNA by virtue of its interaction with this trimeric complex. Alternatively, the association of U3 with pre-rRNA may create or expose the binding site for the hImp3-hImp4-hMpp10 complex.
Mpp10 association with U3 snoRNA requires sequence elements that are important for base pairing with the 5¢ ETS of the pre-rRNA (S.Granneman, N.J.Watkins, J.Vogelzangs, R.Lu Èhrmann, W.J.van Venrooij and G.J.M.Pruijn, manuscript in preparation) (34) . In addition, a C-terminal truncation of the yeast Mpp10p led to cold sensitivity and pre-rRNA processing defects at A 1 and A 2 (36, 45) . A similar processing defect and growth phenotype has been observed in a yeast strain bearing mutations in box A that block base-pairing with 18S rRNA sequences (13) . Thus hMpp10, together with hImp3 and hImp4, might function by facilitating or stabilizing basepairing interactions between U3 snoRNA and the pre-rRNA.
Imp3 is believed to mediate the association of the heterotrimeric complex with the U3 snoRNA (36) . A possible explanation for the partial complementation of the yeast imp3 null allele by mImp3 would be that this mouse protein is incapable of interacting with the yeast Mpp10p. However, mImp3 interacts in a two-hybrid system with yeast Mpp10p to the same degree as yeast Imp3p (data not shown). The observation that over-expression of the yeast U3 snoRNA also partially alleviated the growth defect indicates that the interactions between mImp3 and the yeast U3 snoRNA may be inef®cient, resulting in a growth defect at permissive temperatures.
Formation of the hImp3-hMpp10-hImp4 complex correlates with the nucleolar localization of these proteins Surprisingly, the analysis of deletion mutants showed that the putative RNA binding domains of hImp3 (S4 domain) and hImp4 (s 70 -like motif) are required for their binding to hMpp10 in vitro. Although it is possible that the observed effects are (in part) due to conformational changes in the mutant proteins caused by the deletions or substitutions, the correlation between their interactions in vitro and their nucleolar accumulation is intriguing and strongly suggests that the entry of hImp3, hImp4 and hMpp10 into the nucleolus is dependent on formation of the ternary complex. 
The human SSU processome
The presence of the U3 snoRNA in both 12S and 60±80S complexes raises the question of whether the label U3 snoRNP is entirely accurate. Like in yeast (16, 48) , the hU3-55K and the common box C/D snoRNP proteins are associated with the human 12S U3 complex (this work; S.Granneman, N.J.Watkins, J.Vogelzangs, R.Lu Èhrmann, W.J.van Venrooij and G.J.M.Pruijn, manuscript in preparation). However, the majority of the U3-speci®c proteins in yeast, including Imp3p, Imp4p and Mpp10p, seem to be preferentially or exclusively associated with the U3 snoRNA in higher order complexes (26, 42, 43, 49) . Based on the relatively well de®ned composition of the 12S complex, we propose to name this complex the U3 snoRNP and the 60±80S U3-containing complexes the human SSU processome. 
